Facet Biotech shareholder Baupost buys 385,000 shares for 17.8% stake

By Lisa Kerner

Charlotte, N.C., April 8 - Facet Biotech Corp. shareholders led by Baupost Group, LLC purchased 385,000 shares of the company's stock between Feb. 12 and March 18.

The shares were priced from $6.30 to $7.19 each, according to a schedule 13D filed with the Securities and Exchange Commission on Wednesday.

Baupost beneficially owns 4,374,407 shares, or 17.8%, of the Redwood City, Calif., biotechnology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.